1. Home
  2. AMBO vs EDSA Comparison

AMBO vs EDSA Comparison

Compare AMBO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$4.18

Market Cap

11.9M

Sector

Real Estate

ML Signal

HOLD

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$1.75

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
EDSA
Founded
2000
2015
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9M
12.8M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AMBO
EDSA
Price
$4.18
$1.75
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
18.9K
29.0K
Earning Date
08-05-2025
12-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$9,699,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.07
N/A
Revenue Growth
23.73
N/A
52 Week Low
$1.32
$1.55
52 Week High
$6.75
$4.49

Technical Indicators

Market Signals
Indicator
AMBO
EDSA
Relative Strength Index (RSI) 50.33 43.84
Support Level $4.12 $1.67
Resistance Level $5.25 $1.78
Average True Range (ATR) 0.53 0.07
MACD 0.02 0.03
Stochastic Oscillator 33.12 68.73

Price Performance

Historical Comparison
AMBO
EDSA

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: